Could a simple test catch ALS before symptoms start?
NCT ID NCT07213440
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 37 times
Summary
This study aims to find early markers for ALS, a disease that affects nerve cells and muscles. Researchers will compare blood, tears, urine, and spinal fluid from 60 people—including those with ALS gene mutations but no symptoms, early-stage ALS patients, and healthy controls. The goal is to develop a way to diagnose ALS earlier, which could lead to more effective treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS ALS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Tours
RECRUITINGTours, France, 37000, France
Contact Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.